BiotechTube

Deep neuromuscular block + Moderate neuromuscular block

ApprovedUNKNOWN
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Neuromuscular Block

Conditions

Neuromuscular Block

Trial Timeline

Mar 1, 2016 → Dec 1, 2016

NCT ID
NCT02648503

About Deep neuromuscular block + Moderate neuromuscular block

Deep neuromuscular block + Moderate neuromuscular block is a approved stage product being developed by Merck for Neuromuscular Block. The current trial status is unknown. This product is registered under clinical trial identifier NCT02648503. Target conditions include Neuromuscular Block.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT02648503ApprovedUNKNOWN

Competing Products

20 competing products in Neuromuscular Block

See all competitors
ProductCompanyStageHype Score
HRS-9190; under Inhalational Anesthesia + HRS-9190; under Intravenous Anesthesia + Cisatracurium (under Inhalational Anesthesia). + Cisatracurium (under Intravenous Anesthesia)Jiangsu Hengrui MedicinePhase 2
52
HRS-9190 + HRS-9190 + HRS-9190 + HRS-9190 + Rocuronium + RocuroniumJiangsu Hengrui MedicinePhase 2
52
HRS-9190 + HRS-9190 + HRS-9190Jiangsu Hengrui MedicinePhase 2
52
Placebo + Sugammadex + Esmeron®MerckPhase 2
52
Sugammadex 2 mg/kg + Sugammadex 4 mg/kg + Sugammadex 16 mg/kg + Neostigmine + Glycopyrrolate + Rocuronium + VecuroniumMerckApproved
85
Rocuronium + Succinylcholine + Cisatracurium + Mivacurium + Sugammadex + NeostigmineMerckPre-clinical
23
Sugammadex + RocuroniumMerckApproved
85
sufficient dose of rocuronium + sugammadex 10 min after position changeMerckApproved
85
neostigmine/glycopyrrolate + sugammadexMerckApproved
85
sugammadexMerckPhase 3
77
2 mg/kg sugammadex + 0.07 mg/kg neostigmineMerckPhase 3
77
Sugammadex 2 mg/kg + Sugammadex 4 mg/kg + Neostigmine + Glycopyrrolate + Neostigmine + AtropineMerckApproved
85
Rocuronium + Sugammadex + Cisatracurium + Neostigmine/Atropine + SuccinylcholineMerckApproved
85
Sugammadex + NeostigmineMerckApproved
85
Sugammadex 2 mg/kg ABW + Sugammadex 2 mg/kg IBW + Sugammadex 4 mg/kg ABW + Sugammadex 4 mg/kg IBW + Neostigmine + Glycopyrrolate + Rocuronium or VecuroniumMerckApproved
85
sugammadex + Neostigmine + GlycopyrrolateMerckApproved
85
Group A. "Muscle relaxant #1": rocuronium + sugammadex; "Muscle relaxant #2": succinylcholine +saline + Group B. "Muscle relaxant #2": succinylcholine +saline; "Muscle relaxant #1": rocuronium + sugammadex;MerckPhase 2
52
Sugammadex 2 mg/kg + Sugammadex 4 mg/kg + Neostigmine + Glycopyrrolate + Neostigmine + AtropineMerckApproved
85
Rocuronium Bromide + Rocuronium BromideMerckApproved
85
Rocuronium (moderate NMB) + Rocuronium (deep NMB)MerckPre-clinical
23

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85